MENU
CABA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cabaletta Bio (CABA) Ownership - Who owns Cabaletta Bio?
Profile
Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
103
Web
https://www.cabalettabio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
219.33M
P/E Ratio
N/A
Total Cash
203.23M
Projected Growth
N/A
Total Debt
7.4M
Revenue
N/A
Risk (Beta)
3.35
Dividend Yield
N/A
Total Cash/Share
4.16
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CABA
Capitalization
219M
P/E Ratio
N/A
Risk (Beta)
3.35
Dividend Yield
N/A
Total Cash
203M
Total Cash/Share
4.16
Total Debt
7.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
200M
P/B Ratio
1.10
Cash Flow
N/A
Earnings
-1.91
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
11.52
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-98.61M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-44.76
Shares Held By Institutions
485M
Shares Outstanding - Current
48.8M
Total Liabilities
17.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-79.824
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
103
Web
https://www.cabalettabio.com